Ohio

Next 5-11 years old to get vaccine approval after studying at Cincinnati Children

A study conducted at the Cincinnati Children’s Hospital is one step closer to the availability of vaccines for children ages 5-11 as the Food and Drug Administration seeks to review data from Pfizer. Pfizer released information on a study of children aged 5-11 on Monday morning. 11. The vaccine states that it is safe and effective. The company submits information to the FDA in the hope of reducing the age of emergency orders to children up to the age of five. Some studies were conducted in a children’s hospital and were led by a doctor. Robert Frenck “We were one of the six sites in the country that were conducting dose-ranging studies for vaccine trials,” Frenck said. The dose for children aged 5 to 11 years is about one-third that given to adults. .. “What we found was that the side effects of children were exactly what we saw in adults,” Frenck said. “The most common are injection site pain and headaches and malaise. Fever and chills are rare, probably 10 to 11 percent.” Frank also led the first Pfizer trial in adults. bottom. He said he was confident in the safety of the vaccine. “We’re not going to find anything else we know about vaccines. No surprises. If you haven’t been given hundreds of millions of times, you won’t see it,” Frenck said. Two children aged 5-11 who participated in a group study spoke to WLWT in May. I was very nervous. I thought there were a lot of things that didn’t work, but there are many more things that worked, “said EliDropic, a 10-year-old research participant. Two brothers who were part of a study involving teens. The mother of the child is Dr. Amanda Dropic, a pediatrician. “People say,’Oh, I don’t know what the vaccine does.'” I don’t want my children to be infected with COVID, “Dropic said.

A study conducted at the Cincinnati Children’s Hospital is one step closer to the availability of vaccines for children ages 5-11 as the Food and Drug Administration seeks to review data from Pfizer.

Pfizer released information on a study of children aged 5 to 11 years old, saying the vaccine is safe and effective on Monday morning.

The company submits information to the FDA in hopes of lowering the age of emergency orders for children up to the age of five.

Some studies were conducted in a children’s hospital and were led by Dr. Robert Frenck.

“We were one of the six sites in the country that were conducting dose-ranging studies for vaccine studies,” Frenck said.

The dose between the ages of 5 and 11 is about one-third of the dose given to adults.

“What we found was that the side effects of children were exactly what we saw in adults,” Frenck said. “The most common are injection site pain and headaches and malaise. Fever and chills are rare, probably 10 to 11 percent.”

Frenck also led the first Pfizer trial in adults. He said he was confident in the safety of the vaccine.

“What we know about vaccines isn’t going to find anything else. No surprises. If you haven’t seen it in hundreds of millions of doses, you wouldn’t see it. “Frenck said.

Two children who participated in a group study between the ages of 5 and 11 told WLWT in May about it.

“I was very nervous. I thought there were a lot of things that didn’t work, but there are many more things that worked,” said 10-year-old research participant Eli Dropic.

He and his sister, Lira Dropic, participated in a children’s study with two siblings who participated in a study of teenagers. The mother of the child is Dr. Amanda Dropic, a pediatrician.

“People say,’Oh, you don’t know what the vaccine does,’ well, we don’t know, but we know what COVID does, and I tell my kids I don’t want to get a COVID, “Dropic said.

Next 5-11 years old to get vaccine approval after studying at Cincinnati Children

Source link Next 5-11 years old to get vaccine approval after studying at Cincinnati Children

Related Articles

Back to top button